NLCPharma

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovir and Tollovid Inhibitor Activity

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. announced that its mechanism-based …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovir and Tollovid Inhibitor Activity Read More »

Breaking News: Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. announced that its mechanism-based 3CL protease inhibitors Tollovir® and Tollovid™ that target the active site of the 3CL protease showed robust inhibitory activity against the 3CL protease of the BA.1 and BA.2 strains of the …

Breaking News: Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Acquisition and IP from NLC Pharma

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has completed the acquisition of all 3CL protease biology-related assets and formed a …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Acquisition and IP from NLC Pharma Read More »

Breaking News: Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has completed the acquisition of all 3CL protease biology-related assets and formed a majority-owned subsidiary called 3CL Pharma Ltd. (“3CL Pharma”). 3CL Pharma will focus on developing therapeutics, diagnostics and dietary supplements based on 3CL protease (3CLpro, Main Protease, …

Breaking News: Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Data Lock in Tollovir Phase 2 Clinical Trial

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Data Lock in Tollovir Phase 2 Clinical Trial Read More »

Breaking News: Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients

Breaking News, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma Ltd., today announced a data lock for the interim data analysis for the Company’s Tollovir™ Phase 2 Clinical Trial for the treatment of hospitalized (severe/critical) COVID-19 patients. The Company will release …

Breaking News: Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial Results

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Market Buzz

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL biology-focused joint …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial Results Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) 31 Patients Complete Phase 2 Clinical Trial

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL biology-focused joint …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) 31 Patients Complete Phase 2 Clinical Trial Read More »

Breaking News: Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL biology-focused joint venture partner NLC Pharma, today announced that all 31 patients enrolled to date in Tollovir® Phase 2 clinical trial in hospitalized COVID-19 patients have completed study participation and the data are now being entered into the …

Breaking News: Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Agreement with NLC Pharma

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has entered into a binding agreement to …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Agreement with NLC Pharma Read More »

Stay Connected

Twitter Linkedin-in Instagram Facebook-f Youtube

Subscribe

Subscribe
Subscribe